Sign in
4

Changes in Ownership

aTYR PHARMA INC Filed Acc 0000950170-25-004151

Options or other derivatives

  • President and CEO acquired 1,000,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Shukla Sanjay President and CEO 2025-01-08 Grant or award · Employee Stock Option (right to buy) +1,000,000 1,000,000 D
Loading xslF345X05/ownership.xml…